| Financial Year |
March 31 2023 |
| Monetary Funds |
919,329,331.30 |
| Held-for-trading Financial Assets |
3,200.40 |
| Notes Receivable |
32,080,284.49 |
| Accounts Receivable |
1,145,902,572.92 |
| Advances to Suppliers |
30,629,378.24 |
| Other Receivables |
187,859,984.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,321,747,145.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
207,327,291.85 |
| Total Current Assets |
3,869,966,263.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,744,926.87 |
| Long-term Equity Investment |
436,737,941.98 |
| Investment Properties |
139,401,315.60 |
| Fixed Assetes |
1,007,274,762.82 |
| Under-construction Projects |
1,251,410,977.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
458,511,939.40 |
| R&D expenses |
-- |
| Goodwill |
73,322,469.26 |
| Long-Term Deferred and Prepaid Expenses |
84,567,501.57 |
| Deferred Income Tax Assets |
518,044,975.47 |
| Other Non-Current Assets |
395,438,294.94 |
| Sub-Total of Non-Current Assets |
4,649,403,058.53 |
| Total Assets |
8,519,369,322.23 |
| Short-Term Loans |
2,842,787,305.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
469,256,682.80 |
| Accounts Payable |
1,414,670,037.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,785,358.09 |
| Taxes Payable |
45,204,366.94 |
| Interest Payable |
-- |
| Dividend Payable |
91,325.61 |
| Other payables |
769,203,397.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
667,511,240.82 |
| Other Current Liabilities |
18,943,378.19 |
| Sub-Total of Current Liabilities |
7,027,799,978.91 |
| Long-term Loans |
219,673,372.31 |
| Bonds Payable |
517,347,886.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,167,670.00 |
| Deferred Income Tax Liabilities |
6,281,949.91 |
| Other Non-Current Liabilities |
756,000.00 |
| Sub-Total of Non-Current Liabilities |
842,775,372.98 |
| Total Liabilities |
7,870,575,351.89 |
| Paid-In Capital(Or Share Stock) |
1,408,349,147.00 |
| Capital Surplus |
1,910,086,782.94 |
| Surplus Reserve |
134,505,883.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,852,728,190.79 |
| Minority Stockholder's Interest |
33,288,971.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
615,504,998.48 |
| Owner's Equity（Stockholder's Equity） |
648,793,970.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,519,369,322.23 |
